Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Bioflamex CorpFinancial_Report.xls
EX-32.1 - EXHIBIT 32.1 - Bioflamex Corpex32_1.htm
EX-31.2 - EXHIBIT 31.2 - Bioflamex Corpex31_2.htm
EX-31.1 - EXHIBIT 31.1 - Bioflamex Corpex31_1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q /A

Amendment No. 1

 

[X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
  For the quarterly period ended August 31, 2011
 
[  ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
 
For the transition period from to __________
 
Commission File Number: 000-53712

 

Bioflamex Corporation

(Exact name of registrant as specified in its charter)

 

Nevada Pending
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

 

Christiansvej 31, 2920 Charlottenlund, Denmark
(Address of principal executive offices)

 

646-233-1310
(Registrant’s telephone number)
 
_______________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days [X] Yes [ ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [ ] Yes [X] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

[ ] Large accelerated filer Accelerated filer [ ] Non-accelerated filer
[X] Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

 

State the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 92,466,667 common shares as of August 31, 2011.

 

   

EXPLANATORY NOTE

 

Bioflamex Corporation is filing this Amendment No. 1 to its 10-Q for the quarter ended August 31, 2011 that was originally filed on October 12, 2011. This Amendment No. 1 contains restated financial statements for the quarter ended August 31, 2011 to properly reflect previously unrecorded liabilities for various consulting agreements which were in effect that aggregate approximately $247,500 and $222,200 as of August 31, 2011 and February 28, 2011, respectively. These unrecorded liabilities will affect the Company’s expenses for the period indicated. These consulting agreements were not reported as a result of material weaknesses in internal control over financial reporting. These material weaknesses include: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines.

2

 

TABLE OF CONTENTS

 

Page

 

PART I – FINANCIAL INFORMATION

 

Item 1: Financial Statements 4
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 5
Item 3: Quantitative and Qualitative Disclosures About Market Risk 7
Item 4: Controls and Procedures 8

 

PART II – OTHER INFORMATION

 

Item 1: Legal Proceedings 9
Item 1A: Risk Factors 9
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 9
Item 3: Defaults Upon Senior Securities 9
Item 4: Removed and Reserved 9
Item 5: Other Information 9
Item 6: Exhibits 9
3

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Our financial statements included in this Form 10-Q are as follows:

 

F-1 Condensed Balance Sheet as of August 31, 2011 (restated) and February 28, 2011 (restated) (unaudited);
F-2 Condensed Statements of Operations for the three and six months ended August 31, 2011 (restated) and 2010 and period from August 25, 2004 (Inception) to August 31, 2011 (restated) (unaudited);
F-3 Condensed Statements of Cash Flows for the six months ended August 31, 2011 (restated) and 2010 and period from August 25, 2004 (Inception) to August 31, 2011 (restated) (unaudited);
F-4 Notes to Condensed Financial Statements (restated).

 

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended August 31, 2011 are not necessarily indicative of the results that can be expected for the full year.

4

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

CONDENSED BALANCE SHEETS

 

  August 31, 2011   February 28, 2011 
  (restated)   (restated) 
ASSETS        
Current assets:                
Cash and cash equivalents   $ 96     $ 59  
Prepaid expenses     10,000       10,000  
Total current assets     10,096       10,059  
Other assets:                
Intellectual property (Note 3)     1,191,000       1,191,000  
Total assets   $ 1,201,096     $ 1,201,059  
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current liabilities:                
Accounts payable and accrued expenses   $ 126,276     $ 30,583  
Accrued expenses – related party     368       —    
Convertible note payable     54,605       60,500  
Total current liabilities     181,249       91,083  
Stockholders’ equity                
Common stock; par value $0.0001, 200,000,000 shares authorized, 92,466,667 issued and outstanding at August 31, 2011 and February 28, 2011     9,247       9,247  
Additional paid in capital     1,666,245       1,457,453  
Common stock authorized and unissued, 2,333,334 and 1,000,000 shares at August 31, 2011 and February 28, 2011, respectively     233       100  
Foreign currency translation     (98 )     (70 )
Deficit accumulated in the development stage     (655,780 )     (356,754 )
Total stockholders’ equity     1,019,847       1,109,976  
Total liabilities and stockholders’ equity   $ 1,201,096     $ 1,201,059  

 

The accompanying notes are an integral part of these condensed financial statements.

F-1

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

CONDENSED STATEMENTS OF OPERATIONS

 

  For the Three Months Ended   For the Six Months Ended    August 25, 2004 
  August 31,   August 31,    (Inception) to 
    2011   2010   2011   2010   August 31, 2011
  (Restated)                (Restated)
                                         
Revenue   $ —       $ —       $ —       $ —       $ —    
Operating expenses:                                        
Consulting fees     201,229       —         248,479       —         465,854  
Exploration costs     —         500       —         500       16,500  
General and administrative     6,007       6,524       11,201       4,355       40,818  
Professional fees     7,088       4,500       36,276       15,220       129,538  
Total operating expenses     214,324       11,524       295,956       20,075       652,710  
Net operating loss     (214,324 )     (11,524 )     (295,956 )     (20,075 )     (652,710 )
Other income (expense):                                        
Gain (loss) on foreign currency     (42 )     —         (42 )     —         (42 )
Interest income     2       —         2       —         2  
Interest expense     (1,077 )     —         (3,030 )     —         (3,030 )
Total other income (expense)     (1,117 )     —         (3,070 )     —         (3,070 )
Net loss   $ (215,441 )   $ (11,524 )   $ (299,026 )   $ (20,075 )   $ (655,780 )
Net loss per share -                                        
Basic and fully diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.00 )        
Weighted average number of shares outstanding -Basic and fully diluted     93,975,935       130,110,000       93,787,290       130,110,000          

 

 

The accompanying notes are an integral part of these condensed financial statements.

F-2

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

CONDENSED STATEMENTS OF CASH FLOWS

 

    For the Six Months Ended     August 25, 2004
    August 31,    (Inception) to  
    2011   2010   August 31, 2011
    (Restated)       (Restated)
Cash flows from operating activities:                        
Net operating (loss)   $ (299,026 )   $ (20,075 )   $ (655,780 )
Impairment of mineral rights     —         —         16,500  
Amortization of interest     3,030       —         3,030  
Shares issued for services     150,000       —         350,000  
Changes in operating assets and liabilities                        
(Increase) in prepaid expenses     —         —         (10,000 )
Increase in accounts payable and accrued expenses     95,665       12,483       126,178  
Increase in accrued expenses – related party     368       —         368  
Net cash (used) by operating activities     (49,963 )     (7,592 )     (170,204 )
                         
Cash flows from investing activities:                        
Investment in mineral rights     —         —         (16,000 )
Net cash (used) in investing activities     —         —         (16,000 )
                         
Cash flows from financing activities:                        
Proceeds from notes payable – related party     —         7,500       18,689  
Payments on notes payable – related party     —         —         (18,689 )
Proceeds from convertible notes payable     —         —         60,500  
Proceeds from the sale of common stock     50,000       —         125,800  
Net cash provided by financing activities     50,000       7,500       186,300  
                         
Net increase (decrease) in cash     37       (92 )     96  
Cash – beginning     59       96       —    
Cash – ending   $ 96     $ 4     $ 96  
                         
Supplemental disclosures:                        
Interest paid   $ —       $ —       $ —    
Income taxes paid   $ —       $ —       $ —    
                         
Non-cash supplemental disclosures:                        
Shares issued for asset acquisition   $ —       $ —       $ 1,191,000  
Shares issued for services   $ 150,000     $ —       $ 350,000  


The accompanying notes are an integral part of these condensed financial statements

F-3

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2011

(RESTATED)

 

NOTE 1 – NATURE OF OPERATIONS

 

The accompanying unaudited interim financial statements have been prepared by Bioflamex Corp. (the “Company”) pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments and disclosures necessary for a fair presentation of these financial statements have been included. Such adjustments consist of normal recurring adjustments. These interim financial statements should be read in conjunction with the restated audited financial statements of the Company for the fiscal year ended February 28, 2011.

 

The results of operations for the six months ended August 31, 2011 are not indicative of the results that may be expected for the full year.

 

The Company was incorporated as Deer Bay Resources Inc. in the State of Nevada, United States of America on August 25, 2004. The Company’s fiscal year end is February 28, 2011.

 

The Company’s principal business up to January 25, 2011 was the acquisition and exploration of mineral resources. On January 25, 2011, the Company entered into an Asset Purchase Agreement to acquire certain intellectual property related to a line of fire extinguishing and prevention products that are based on environment friendly and biological formulations. In consideration for the newly acquired assets, the Company issued 38,000,000 shares at $ 0.013 per share. We have not produced any revenues from the Company’s newly acquired assets or commenced significant business operations and are considered a development stage company as defined by SEC Guide 7 with reference to Financial Accounting Standards Board (FASB) issued Accounting Standards Codification (ASC) topic 915.

 

The Company's financial statements are prepared using the accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has not begun to generate significant revenues, and has incurred a significant operating loss as of August 31, 2011.

 

T he Company is dependent upon its ability to secure equity and/or debt financing and there are no assurances that the Company will be successful. Without sufficient financing, or the achievement of profitable operations, it would be unlikely for the Company to continue as a going concern.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Accounting Basis

These financial statements are prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles of the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. The more significant areas requiring the use of estimates include asset impairment, stock-based compensation, and future income tax amounts. Management bases its estimates on historical experience and on other assumptions considered to be reasonable under the circumstances. However, actual results may differ from the estimates.

F-4

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2011

(RESTATED) 

 

Long –lived Assets

The Company tests long-lived assets or asset groups for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to; significant decreases in the market price of the asset; significant adverse changes in the business climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the assets; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset; and current expectation that the asset will be more likely than not be sold or disposed significantly before the end of its estimated useful life.

 

Loss Per Share

Net income (loss) per common share is computed based on the weighted average number of common shares outstanding and common stock equivalents, if not anti-dilutive. The Company has not issued any potentially dilutive common shares.

 

Basic loss per share is calculated using the weighted average number of common shares outstanding and the treasury stock method is used to calculate diluted earnings per share. For the years presented, this calculation proved to be anti-dilutive.

 

Dividends

The Company has not adopted any policy regarding payment of dividends. No dividends have been paid during the period shown.

 

Revenue Recognition

The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

 

Income Taxes

The Company provides for income taxes using an asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect currently. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. No provision for income taxes is included in the statement due to its immaterial amount, net of the allowance account, based on the likelihood of the Company to utilize the loss carry-forward.

 

Recent Accounting Pronouncements

In June 2009, the FASB issued SFAS 168, The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles. (“SFAS 168” or ASC 105-10) SFAS 168 (ASC 105-10) establishes the Codification as the sole source of authoritative accounting principles recognized by the FASB to be applied by all nongovernmental entities in the preparation of financial statements in conformity with GAAP. SFAS 168 (ASC 105-10) was prospectively effective for financial statements issued for fiscal years ending on or after September 15, 2009 and interim periods within those fiscal years. The adoption of SFAS 168 (ASC 105-10) on July 1, 2009 did not impact the Company’s results of operations or financial condition. The Codification did not change GAAP, however, it did change the way GAAP is organized and presented.

 

As a result, these changes impact how companies reference GAAP in their financial statements and in their significant accounting policies. The Company implemented the Codification in this Report by providing references to the Codification topics alongside references to the corresponding standards.

 

With the exception of the pronouncements noted above, no other accounting standards or interpretations issued or recently adopted are expected to have a material impact on the Company’s financial position, operations or cash flows.

 

F oreign currency transactions

The Company’s functional and reporting currency is the United States dollar. Monetary assets and liabilities denominated in foreign currencies are translated in accordance with ASC 820, using the exchange rate prevailing at the balance sheet date. Gains and losses arising on settlement of foreign currency denominated transactions or balances are included in the determination of income.

F-5

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2011 

(RESTATED) 

   

NOTE 3 – INTANGIBLE ASSETS

 

On January 25, 2011, the Company entered into an Asset Purchase Agreement to acquire certain intellectual property related to a line of fire extinguishing and prevention products that are based on environment friendly and biological formulations. In consideration for the newly acquired assets, the Company issued 38,000,000 shares at $ 0.013 per share, totalling $ 1,190,000 to two individuals who became the entire Board of Directors and the two senior officers of the Company. The Company followed SAB Topic 5 G in determining value as the transaction was considered a non-monetary related party transaction. Value was determined based on historical costs associated with testing, patenting and trademarking the intellectual property and also supported by an independent valuation of the intellectual property. The entire purchase price was allocated to the intangible asset category of Patents and Trademarks.

 

NOTE 4 – CONVERTIBLE DEBT

 

The Company received $60,500 pursuant to a convertible debenture subscription agreement. The loan is convertible into 6,050,000 common shares of the Company at a rate of $ 0.01 of debt for each share issued. The maturity date of this convertible debenture is December 13, 2012. The debenture has no stated rate of interest. Interest was imputed at a rate of 8% providing a discount of $8,925 to be amortized over the term of the agreement. As of August 31, 2011, the Company recorded interest expense of $3,030. The principle balance net of discount was $54,605.

 

NOTE 5 –COMMON STOCK

 

From August 24, 2011 (inception), the Company issued 43,800,000 shares of its restricted common stock at a price of $0.001 per share and total cash proceeds of $43,800.

 

On October 25, 2004, the Company issued 1,050,000 shares of its restricted common stock at a price of $0.01 per share and total cash proceeds of $10,500.

 

On January 5, 2005, the Company issued 260,000 shares of its restricted common stock at a price of $0.05 per share and total cash proceeds of $13,000.

 

On June 24, 2008, the Company issued 85,000,000 shares of its restricted common stock at a price of $0.0001 per share and total cash proceeds of $8,500.

 

On January 25, 2011, the Company issued 38,000,000 shares of its restricted common stock at a price of $0.313 per share or $1,191,111, pursuant to an asset purchase agreement dated January 25, 2011. (See Note 3)

 

On January 25, 2011, in connection with the aforementioned Asset Purchase Agreement, the Company’s former director and chief executive officer returned 75,643,333 shares of common stock for cancellation. The Company recorded a reduction in additional paid in capital of $7,564 representing the par value of the cancelled shares.

 

On January 28, 2011, the Company authorized the issuance of 1,000,000 shares of common stock for to Front Range Consulting for services valued at $200,000. As of August 31, 2011, the shares are unissued.

 

On April 26, 2011, the Company authorized the issuance of 333,334 shares of common stock pursuant to a subscription agreement for cash proceeds of $50,000. As of August 31, 2011, the shares are unissued.

 

On August 15, 2011, the Company authorized the issuance of 1,000,000 shares of common stock to Front Range Consulting for services valued at $150,000. As of August 31, 2011, the shares are unissued.

 

At August 31, 2011, there were no outstanding stock options or warrants.

F-6

BIOFLAMEX CORP.

(formerly Deer Bay Resources Inc.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2011 

(RESTATED) 

 

NOTE 6 - CORRECTION OF ERRORS AND RESTATEMENT

 

In June 2012, the Company identified errors in previously reported financial statements relating to the accrual of various expenses incurred and unrecorded from December 2010 through November 30, 2011. The following table represents the effects of the errors for the six months ended August 31, 2011 and the year ended February 28, 2011.

 

    August 31, 2011   February 28, 2011
    As Originally       As   As Originally       As
      Filed        Corrections        Restated       Filed        Corrections        Restated  
BALANCE SHEET                                                
Current assets                                                
Cash and cash equivalents   $ 96       —       $ 96     $ 59       —       $ 59  
Prepaid expenses - other     10,000       —         10,000       10,000       —         10,000  
   Total current assets     10,096       —         10,096       10,059       —         10,059  
Other assets                                                
Intangible assets:     1,191,000       —         1,191,000       1,191,000       —         1,191,000  
   Total assets   $ 1,201,096       —       $ 1,201,096       1,201,059       —         1,201,059  
                                                 
Current liabilities                                                
Accounts payable and accrued expenses     9,505       116,771       126,276       8,341       22,242       30,583  
Accrued expenses - related party     368       —         368                          
Convertible note     60,500       (5,895 )     54,605       60,500       —         60,500  
   Total current liabilities     70,373       110,876       181,249       68,841       22,242       91,083  
Stockholders' (Deficit)                                                
Common stock     9,280       (33 )     9,247       9,247       —         9,247  
Additional paid-in capital     1,307,520       358,725       1,666,245       1,257,553       —         1,457,453  
Common stock authorized and unissued     —         233       233       —         100       100  
Foreign currency translation     —         (98 )     (98 )     —         (70 )     (70 )
Accumulated deficit     (186,077 )     (469,703 )     (655,780 )     (134,582 )     (222,172 )     (356,754 )
   Total stockholders' equity     1,130,723       (110,876 )     1,019,847       1,132,218       (222,142 )     1,109,976  
   Total liabilities and stockholders' (deficit)   $ 1,201,096       —       $ 1,201,096     $ 1,201,059       (199,900 )   $ 1,201,059  
                                                 
STATEMENT OF OPERATIONS                                                
Revenues   $ —         —       $ —                            
Operating Expenses                                                
Consulting fees     3,979       244,500       248,479                          
Office expense     11,201       —         11,201                          
Professional fees     36,276       —         36,276                          
   Total operating expenses     51,456       244,500       295,956                          
                                                 
Gain (loss) on foreign currency     —         (42 )     (42 )                        
Interest income     —         2       2                          
Interest expense     —         (3,030 )     (3,030 )                        
Net (loss)   $ (51,456 )     (247,530 )   $ (299,026 )                        
Basic and diluted loss per share   $ (0.00 )     —       $ (0.00 )                        
Weighted average shares outstanding     92,699,929       1,087,361       93,787,290                          

 

NOTE 7 – SUBSEQUENT EVENTS

 

The Company has analyzed its operations subsequent to August 31, 2011 through the date the financial statements were submitted to the Securities and Exchange Commission and has determined that it does not have any additional material subsequent events to disclose in these financial statements.

 

F-7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse affect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the SEC.

 

Company Overview

 

We are in the business of developing, producing, and marketing high performance fire extinguishing and prevention products that are based on environment friendly and biological formulations. We intend to build a leading position within the niche of environmentally friendly fire fighting and prevention solutions in the United States and internationally, both through organic growth and the acquisition of complementary companies and patents. We believe the time is right for our products. The general emphasis on environmental protection and the increased focus on health hazards in chemicals used in conventional fire fighting products paves the way for the substitution of chemical-based fire combatant products with “greener,” non-harmful products.

 

Fire extinguishers available on the market today mainly use dry chemical powder, chemical foam, CO2 or halon type of gaseous media as bases. These products in general will extinguish fires with varying efficacy, but most also contain chemical substances that harm the environment or compose a hazard to people. In addition, they can be messy and damage metals (corrosion), increasing the collateral damage. Our products offer water-based clean alternatives which are completely harmless to humans and the environment, and are non-toxic. Combined with their exceptional extinguishing characteristics, we believe these products point to the future of professional and personal fire fighting. In conventional forest fire fighting, the primary media is water which offers good extinguishing power, but has some drawbacks: it must be used in large quantities; it evaporates relatively quickly; and has a short lifespan in hot environments. Chemical AFFF foams and agents are often used to enhance the fire extinguishing or retardant capabilities, but these chemicals affect the environment and leave long-lasting toxic residue. The toxins found in foams accumulate in the food-chain and are detectable in human organs. We believe our products will have no such negative effect upon life.

 

We are in the final stages of testing and development of our proprietary range of products. Our goal is to develop 5-10 unique product formulations and application concepts covering fire fighting and fire prevention. We intend to market our products under the trademarks Bioflamex® and SAFIRE®. Our goal is to penetrate the key United States and international markets with our “clean” fire extinguishing products and fire retardants.

5

We are currently preparing and submitting United States and international patent applications for our product concepts to ensure the security of our intellectual property rights and enhance the market response to our product propositions. We hope to build a solid portfolio of intellectual property within the industry that can be licensed to third parties. We are currently in the process of applying for patents on our revolutionary products and processes.

 

We are also preparing the materials necessary to complete the necessary tests, approvals and certifications in the United States and key international markets, that are the prerequisite for sales and marketing. With these approvals and certifications, we hope to gain a solid geographical presence in the United States, key markets in Europe, the Middle East and parts of Asia. We intend to work through distribution partners, agents and/or license holders, and through that presence achieve strong sales with the consumers, professional, business, industrial and government service market segments.

 

Results of operations for the three and six months ended August 31, 2011 and 2010, and for the period from Inception (August 25, 2004) to August 31, 2011

 

We have not earned any revenues since our inception on August 25, 2004. We do not anticipate earning revenues until such time that we have fully developed and are able to market our products.

 

We incurred operating expenses in the amount of $214,324 for the three months ended August 31, 2011, compared with operating expenses of $11,524 for the three months ended August 31, 2010. We incurred operating expenses in the amount of $295,956 for the six months ended August 31, 2011, compared with operating expenses of $20,075 for the six months ended August 31, 2010. In all cases, the increase is mainly attributable to consulting fees and professional fees.

 

We incurred operating expenses in the amount of $652,710 for the period from August 25, 2004 (Inception) to August 31, 2011. 

 

We incurred a net loss in the amount of $215,441 for the three months ended August 31, 2011, as compared with a net loss in the amount of $11,524 for the three months ended August 31, 2010. We incurred a net loss in the amount of $299,026 for the six months ended August 31, 2011, as compared with a net loss in the amount of $20,075 for the six months ended August 31, 2010. We incurred a net loss in the amount of $655,780 for the period from August 25, 2004 (Inception) to August 31, 2011. Our losses for each period are attributable to operating expenses together with a lack of any revenues.

 

Liquidity and Capital Resources

 

As of August 31, 2011, we had total current assets of $10,096. Our total current liabilities as of August 31, 2011 were $ 181,249 . As a result, we had a working capital deficit of $171,153 as of August 31, 2011.

 

Operating activities used $49,963 in cash for the six months ended August 31, 2011. Our net loss of $299,026 offset by an increase in accounts payable, accrued expenses of $95,665 and accured expenses owing to a related party of $368 were the contributing factors to our negative operating cash flow. Investing activities used no cash for the six months ended August 31, 2011. Financing activities for the six months ended August 31, 2011 generated $50,000 as a result of the issuance of our common stock.

6

We will require a cash injection of $2,000,000 to begin operations, launch a full marketing and branding campaign, manufacture and deliver products and to begin and increase revenues from its products. In April of 2011, we raised $50,000 in a private placement to an accredited investor. Notwithstanding, as of August 31, 2011, we have insufficient cash to operate our business at the current level for the next twelve months and insufficient cash to achieve our business goals. The success of our business plan beyond the next 12 months is contingent upon us obtaining additional financing. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund our capital expenditures, working capital, or other cash requirements. We do not have any formal commitments or arrangements for the sales of stock or the advancement or loan of funds at this time. There can be no assurance that such additional financing will be available to us on acceptable terms, or at all.

 

Off Balance Sheet Arrangements

 

As of August 31, 2011, there were no off balance sheet arrangements.

 

Going Concern

 

Our financial statements are prepared using the accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, we have not begun to generate significant revenues, and have incurred a significant operating loss as of August 31, 2011.

 

We are dependent upon our ability to secure equity and/or debt financing and there are no assurances that we will be successful. Without sufficient financing, or the achievement of profitable operations, it would be unlikely for us to continue as a going concern.

 

Critical Accounting Policies

 

In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

 

Our accounting policies are set forth in Note 2 to the financial statements. Management does not believe that our accounting policies are critical enough to mention in the body of this quarterly report on Form 10-Q.

 

Recently Issued Accounting Pronouncements

 

We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operation, financial position or cash flow.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

A smaller reporting company is not required to provide the information required by this Item.

7

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

 

We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending February 28, 2012, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

 

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended August 31, 2011 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

8


PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not a party to any pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers, directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse to us.

 

Item 1A:Risk Factors

 

A smaller reporting company is not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None

 

Item 3. Defaults upon Senior Securities

 

None

 

Item 4. Removed and Reserved

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

Exhibit Number Description of Exhibit
31.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
9

 

SIGNATURES

 

In accordance with the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Bioflamex Corporation
 
Date:

July 25, 2012

 

By: /s/ Kristian Schiorring
  Kristian Schiorring
Title: Chief Executive Officer and Director

 

 

 

10